Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Management Comments

Aytu BioScience Announces Enrollment of First Twenty Patients in the Natesto(R) Spermatogenesis StudyJuly 17, 2018 8:07 AM